Premium
Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with knowledge of the development told VCCircle. This would be the third largest M&A deal in the pharmaceutical sector in India, behind ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
